Fenofibrate monotherapy-induced rhabdomyolysis in a patient with type-2 diabetes.
Cetinkaya
Ramazan
R
Uyanik
Abdullah
A
Yildirim
Rahsan
R
Bilen
Yusuf
Y
Keles
Mustafa
M
D003924:Diabetes Mellitus, Type 2 / Q000150:complications*; D005260:Female; D011345:Fenofibrate / Q000009:adverse effects*; D006801:Humans; D006875:Hydrotherapy; D006949:Hyperlipidemias / Q000188:drug therapy; D000960:Hypolipidemic Agents / Q000009:adverse effects*; D008875:Middle Aged; D012206:Rhabdomyolysis / Q000139:chemically induced*; D012307:Risk Factors
D000960:Hypolipidemic Agents; D011345:Fenofibrate